Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124801042 | 12480104 | 2 | F | 20070917 | 20160804 | 20160620 | 20160830 | PER | US-JNJFOC-20160509925 | JANSSEN | 25.84 | YR | A | F | Y | 62.60000 | KG | 20160830 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124801042 | 12480104 | 1 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | 700 MG | N | 14KD87101;14KD87101 +MORE | 0 | 10 | MG/KG | LYOPHILIZED POWDER | |||||
| 124801042 | 12480104 | 2 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | 14KD87101;14KD87101 +MORE | 0 | 10 | MG/KG | LYOPHILIZED POWDER | ||||||
| 124801042 | 12480104 | 3 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | 14KD87101;14KD87101 +MORE | 0 | 500 | MG | LYOPHILIZED POWDER | ||||||
| 124801042 | 12480104 | 4 | SS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | N | 14KD87101;14KD87101 +MORE | 0 | 600 | MG | LYOPHILIZED POWDER | ||||||
| 124801042 | 12480104 | 5 | PS | REMICADE | INFLIXIMAB | 1 | Intravenous (not otherwise specified) | 400 MG | N | 14KD87101;14KD87101 +MORE | 103772 | 5 | MG/KG | LYOPHILIZED POWDER | |||||
| 124801042 | 12480104 | 6 | C | PERCOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | Unknown | AS NEEDED | 0 | UNSPECIFIED | |||||||||
| 124801042 | 12480104 | 7 | C | LUNESTA | ESZOPICLONE | 1 | Unknown | AS NEEDED | 0 | UNSPECIFIED | |||||||||
| 124801042 | 12480104 | 8 | C | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 0 | 10 | MG | UNSPECIFIED | /wk | |||||||
| 124801042 | 12480104 | 9 | C | BETAMETHASONE DIPROPIONATE. | BETAMETHASONE DIPROPIONATE | 1 | Unknown | 0 | LOTION | ||||||||||
| 124801042 | 12480104 | 10 | C | CYCLOBENZAPRINE | CYCLOBENZAPRINE | 1 | Unknown | ONLY AS NEEDED | 0 | 20 | MG | UNSPECIFIED | BID | ||||||
| 124801042 | 12480104 | 11 | C | XANAX | ALPRAZOLAM | 1 | Unknown | AS NEEDED | 0 | UNSPECIFIED | |||||||||
| 124801042 | 12480104 | 12 | C | TEMAZEPAM. | TEMAZEPAM | 1 | Unknown | AS NEEDED | 0 | UNSPECIFIED | |||||||||
| 124801042 | 12480104 | 13 | C | MOMETASONE | MOMETASONE | 1 | Unknown | 0 | LOTION |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124801042 | 12480104 | 1 | Psoriatic arthropathy |
| 124801042 | 12480104 | 2 | Psoriatic arthropathy |
| 124801042 | 12480104 | 3 | Psoriatic arthropathy |
| 124801042 | 12480104 | 4 | Psoriatic arthropathy |
| 124801042 | 12480104 | 5 | Psoriatic arthropathy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124801042 | 12480104 | Drug effect decreased | |
| 124801042 | 12480104 | Incorrect dose administered | |
| 124801042 | 12480104 | Off label use | |
| 124801042 | 12480104 | Psoriatic arthropathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124801042 | 12480104 | 1 | 20140307 | 0 | ||
| 124801042 | 12480104 | 2 | 20160328 | 0 | ||
| 124801042 | 12480104 | 3 | 20070917 | 0 | ||
| 124801042 | 12480104 | 4 | 20110714 | 0 | ||
| 124801042 | 12480104 | 5 | 200707 | 0 |